667 related articles for article (PubMed ID: 18633217)
1. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
2. [Clinical application of FdUrd to meningeal dissemination of malignant tumors].
Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Tsuzuki T; Hirayama A; Yamamoto H; Ikenaka K
No Shinkei Geka; 1998 Nov; 26(11):969-77. PubMed ID: 9834491
[TBL] [Abstract][Full Text] [Related]
3. [Study of meningeal carcinomatosis: diagnosis and treatment].
Nakagawa H; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Kubo S; Hayakawa T
No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
5. [Ventriculo-lumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal dissemination of malignant disease].
Nakagawa H; Fujita T; Kubo S; Izumoto S; Nakajima Y; Tsuruzono K
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1173-9. PubMed ID: 2053775
[TBL] [Abstract][Full Text] [Related]
6. [Diffuse metastatic leptomeningeal carcinomatosis (DMLC)].
Ishikura A; Hunaki N
Gan No Rinsho; 1987 Jul; 33(8):881-4. PubMed ID: 3613110
[TBL] [Abstract][Full Text] [Related]
7. [Case of leptomeningeal carcinomatosis effectively treated with intrathecal chemotherapy using ventriculoperitoneal shunt].
Miura M; Iijima N; Hayashida K; Kitazawa K; Ishii K; Ohara S
Rinsho Shinkeigaku; 2006 Jun; 46(6):404-9. PubMed ID: 16986702
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
10. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
Jaeckle KA; Phuphanich S; Bent MJ; Aiken R; Batchelor T; Campbell T; Fulton D; Gilbert M; Heros D; Rogers L; O'Day SJ; Akerley W; Allen J; Baidas S; Gertler SZ; Greenberg HS; LaFollette S; Lesser G; Mason W; Recht L; Wong E; Chamberlain MC; Cohn A; Glantz MJ; Gutheil JC; Maria B; Moots P; New P; Russell C; Shapiro W; Swinnen L; Howell SB
Br J Cancer; 2001 Jan; 84(2):157-63. PubMed ID: 11161370
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Meningeal Malignancy.
Berg SL; Poplack DG
Oncologist; 1996; 1(1 & 2):56-61. PubMed ID: 10387969
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
Yoshida S; Morii K
Surg Neurol; 2005 Jan; 63(1):52-5; discussion 55. PubMed ID: 15639526
[TBL] [Abstract][Full Text] [Related]
16. [Neoplastic meningitis. Diagnosis and individualised therapy].
Strik H; Prömmel P
Nervenarzt; 2010 Feb; 81(2):229-41; quiz 242. PubMed ID: 20140544
[TBL] [Abstract][Full Text] [Related]
17. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
18. Current status of intrathecal chemotherapy for human meningeal neoplasms.
Bleyer WA
Natl Cancer Inst Monogr; 1977 Dec; 46():171-8. PubMed ID: 580638
[TBL] [Abstract][Full Text] [Related]
19. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
